Ann M. Cunningham

Ann Cunningham is a seasoned professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently, Ann serves as Managing Partner at i3 Strategy Partners, focusing on innovative business strategies and health equity initiatives, and as a board member and Chief Commercial Officer at VistaGen Therapeutics, Inc. Previous roles include Vice President at Teva Pharmaceuticals, where Ann directed global commercial development in Psychiatry and Neurodegenerative Diseases, and Senior Marketing Director at Otsuka Pharmaceutical, leading the launch strategies for key products. Ann's career at Eli Lilly spanned various leadership roles in marketing and sales, significantly impacting product growth and strategy. Ann holds an MBA in Marketing Management from the University of Michigan and a BA in Psychology from Yale University.